Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Friday, November 20, 2009

Second license deal with Amgen to bring ImmunoGen another $35M

By Mass High Tech staff

Waltham biotechnology firm ImmunoGen Inc. has announced a second license granted to Amgen Inc. for its maytansinoid Targeted Antibody Payload technology for an undisclosed target. The deal promises a $1 million upfront payment to ImmunoGen, with up to $34 million in milestone payments and additional royalties — the same agreement the company had with Amgen in September when it licensed the technology for a different undisclosed target.

ImmunoGen’s TAP technology relies on antibodies to deliver cell-killing agents to cancer targets.

As part of the agreement, Thousand Oaks, Calif.-based Amgen will be responsible for the development, manufacturing and marketing of any products related to the license.

This license was taken under an agreement established in 2000 between ImmunoGen (Nasdaq: IMGN) and Abgenix Inc., which later was acquired by Amgen.


 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Bill Gates, Ray Ozzie, Microsoft execs patent 'personal data mining'

By Todd Bishop TechFlash Bill Gates, Ray Ozzie and a bunch of other heavy-hitters from Microsoft are named as inventors on a newly issued patent for a "personal data mining" system that would analyze information and make recommendations with the goal of aiding a person's decisions and improving quality of life. The patent was issued this week, based on a September 2006 patent application. I...

Read More

Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio